Alvotech ALVO
NASDAQ ALVO
$4.24 +0.25 (+6.39%)
At close: Aug 20, 2026 · 11:56 AM UTC

Alvotech (ALVO) Return on Sales (2022 - 2026)

Alvotech's (ALVO) quarterly Return on Sales came in at 0.0% in Q1 2026, down 1.0% YoY from 0.0% in Q1 2025, and down 99.97% on a QoQ basis from 0.08% in Q4 2025.

Alvotech (ALVO) Return on Sales (2022 - 2026) Analysis & Trends

Alvotech (ALVO) has 5 years of Return on Sales data on file, last reported at 0.0% in Q1 2026.

  • Quarterly Return on Sales fell 1.0% year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, up 1.0% from the prior year.
  • Return on Sales retreated to 0.0% in Q1 2026, from 0.08% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.76% in Q2 2022 to a low of 1.3% in Q1 2022.
  • A 5-year average of 0.09% and a median of 0.0% in 2023 frame the typical range for Return on Sales.
  • The widest YoY moves for Return on Sales: up 130 bps in 2023, down 76 bps in 2023.
  • Tracing ALVO's Return on Sales over 5 years: stood at 0.39% in 2022, then advanced by 12 bps to 0.34% in 2023, then soared by 90 bps to 0.03% in 2024, then surged by 328 bps to 0.08% in 2025, then sank by 100 bps to 0.0% in 2026.
  • The last three Return on Sales figures came in at 0.0% (Q1 2026), 0.08% (Q4 2025), and 0.09% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Haleon 44.07 Bn 43.10 Bn - -
2 Teva Pharmaceutical Industries 43.41 Bn 39.75 Bn 2.15 Bn 0.00%
3 Zoetis 31.83 Bn 30.15 Bn 1.05 Bn 0.00%
4 Takeda Pharmaceutical 28.77 Bn 22.97 Bn 5.10 Bn 0.00%
5 United Therapeutics 22.27 Bn 19.61 Bn 683.80 Mn 0.00%
6 Viatris 18.76 Bn 17.87 Bn 1.46 Bn 0.00%
7 Neurocrine Biosciences 15.65 Bn 15.26 Bn 935.80 Mn 0.00%
8 Elanco Animal Health 11.93 Bn 11.40 Bn 798.00 Mn 0.00%
9 Dr Reddys Laboratories 10.16 Bn 10.00 Bn - -
10 Alvotech 1.25 Bn 1.25 Bn 5.09 Mn 0.00%

Historic Data

Download Data
DateValue
Mar 31, 2026 0.00%
Dec 31, 2025 0.08%
Sep 30, 2025 -0.09%
Jun 30, 2025 0.01%
Mar 31, 2025 0.01%
Dec 31, 2024 -0.03%
Sep 30, 2024 -0.05%
Jun 30, 2024 0.00%
Mar 31, 2024 0.00%
Dec 31, 2023 -0.34%
Jun 30, 2023 0.00%
Mar 31, 2023 0.00%
Dec 31, 2022 -0.39%
Jun 30, 2022 0.76%
Mar 31, 2022 -1.30%